Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.9116 per EA under NDC 62332037931. Its NADAC has been published 361 times since Jul 31, 2019.
Strength
7.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332037931
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA211542On Market Since
11/27/2018
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 361 times since Jul 31, 2019, and over the history we have for it it has declined 56.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9116 per EA |
|---|---|
| All-time high | $2.0748 (Aug 14, 2019) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9430 |
| 52-week low | $0.7894 |
| Median price | $1.2730 |
| Average price | $1.2883 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 361 |
| Tracking since | Jul 31, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.9116 per EA (NDC 62332037931), effective Jun 24, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has declined 56.1%. It has been tracked across 361 weekly CMS publications since Jul 31, 2019.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Jul 31, 2019, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $2.0748 (Aug 14, 2019), with a median of $1.2730 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 7.5 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 62332037931) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification